The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Brilinta, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (ACS) or a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event (see Dosage & Administration; and Pharmacology: Pharmacodynamics under Actions).
Sign Out
Continue with Google